The new tax law has nearly doubled the standard deduction and limits the deduction for state and local taxes, making it less likely for taxpayers to itemize their deductions.

J.P. Morgan hired 160 brokers last fiscal year, and it’s not slowing down in 2018.

The gig economy ushered in a new way of working, which in turn has ushered in a new way of retiring.

Nearly three-in-four advisors (73%) do not have a succession plan in place.

The No. 7 IBD has unveiled five new internal classifications for practices in an effort, it says, to boost the customization of its services for advisors.

The advisory firm left Securities America to make the move.

The health-care program for the elderly and disabled covers about 58 million Americans.

The acquisition will expand the Milwaukee-based firm's presence in the Northeast.

At least seven firms with outside RIAs have left the No. 1 IBD since it announced a change in policies last November.

Clients should not only check the fees, but also compare their after-tax returns.

About 4.3 million of the 18 million workers in the 55-64 age bracket are likely to live in poverty once they reach 65, according to a study.

Hilliard Lyons, not traditionally known for big recruiting pushes, is expanding.

Wirehouses have made some recruiting mistakes in recent years. Meanwhile some aspects of corporate strategy are being done right in certain pockets of the industry. Danny Sarch offers his insight as we continue the dialogue from our Recruiters Roundtable.

“It’s incredibly important to have diversity. Period,” says Kara Murphy.

Ex-employee charges that African-Americans are denied opportunities at the brokerage giant in a climate of institutional discrimination.

If wirehouses decided to adopt a salary-plus-bonus compensation model, how would they do it?

Shifts in the annual ranking of the nation's independent broker-dealers show how pressure on IBDs is intensifying.

This interactive tool provides the full collection of data from Financial Planning's 33rd annual study of the largest firms in the space.

The gap for brand-name prescription drugs for Medicare beneficiaries is likely to narrow down to 25% of drug costs from the scheduled 30% next year.

Wells Fargo’s advisor headcount continues to fall in the second quarter.